Pfam Domains GO Terms
| Lipocalin |
| retinoid binding |
| retinoic acid biosynthetic process |
| diterpenoid biosynthetic process |
| retinal binding |
| positive regulation of collateral sprouting |
| retinol binding |
| terpenoid biosynthetic process |
| regulation of retinoic acid receptor signaling pathway |
| regulation of collateral sprouting |
| retinoic acid binding |
| isoprenoid biosynthetic process |
| retinoic acid metabolic process |
| embryonic forelimb morphogenesis |
| forelimb morphogenesis |
| positive regulation of axonogenesis |
| retinoid metabolic process |
| diterpenoid metabolic process |
| regulation of extent of cell growth |
| terpenoid metabolic process |
| cellular hormone metabolic process |
| embryonic limb morphogenesis |
| embryonic appendage morphogenesis |
| isoprenoid metabolic process |
| limb morphogenesis |
| appendage morphogenesis |
| positive regulation of cell morphogenesis involved in differentiation |
| positive regulation of cell growth |
| positive regulation of developmental growth |
| appendage development |
| limb development |
| regulation of cell size |
| regulation of axonogenesis |
| monocarboxylic acid biosynthetic process |
| hormone metabolic process |
| positive regulation of growth |
| positive regulation of neuron projection development |
| carboxylic acid biosynthetic process |
| regulation of cell morphogenesis involved in differentiation |
| organic acid biosynthetic process |
| regulation of developmental growth |
| positive regulation of neuron differentiation |
| regulation of cellular component size |
| positive regulation of cell projection organization |
| epidermis development |
| regulation of cell growth |
| positive regulation of neurogenesis |
| regulation of cell morphogenesis |
| regulation of neuron projection development |
| regulation of anatomical structure size |
| monocarboxylic acid metabolic process |
| regulation of hormone levels |
| positive regulation of nervous system development |
| positive regulation of cell development |
| embryonic morphogenesis |
| lipid biosynthetic process |
| small molecule biosynthetic process |
| regulation of neuron differentiation |
| regulation of growth |
| regulation of plasma membrane bounded cell projection organization |
| regulation of cell projection organization |
| regulation of neurogenesis |
| carboxylic acid metabolic process |
| regulation of nervous system development |
| regulation of cell development |
| cellular lipid metabolic process |
| positive regulation of cell differentiation |
| embryo development |
| oxoacid metabolic process |
| endoplasmic reticulum |
| organic acid metabolic process |
| regulation of anatomical structure morphogenesis |
| positive regulation of cellular component organization |
| lipid metabolic process |
| positive regulation of developmental process |
| generation of neurons |
| neurogenesis |
| positive regulation of multicellular organismal process |
| small molecule metabolic process |
| tissue development |
| regulation of cell differentiation |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 1/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution